Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Silo Pharma (SILO) over the last 6 years, with Q3 2025 value amounting to $886.0.

  • Silo Pharma's Interest Expenses fell 1803.89% to $886.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4874.0, marking a year-over-year decrease of 411.17%. This contributed to the annual value of $5084.0 for FY2024, which is 441.57% up from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Interest Expenses is $886.0, which was down 1803.89% from $1648.0 recorded in Q2 2025.
  • Silo Pharma's 5-year Interest Expenses high stood at $2066.0 for Q1 2025, and its period low was $164.0 during Q4 2021.
  • In the last 4 years, Silo Pharma's Interest Expenses had a median value of $1081.0 in 2024 and averaged $1172.6.
  • Within the past 5 years, the most significant YoY rise in Silo Pharma's Interest Expenses was 24893.62% (2021), while the steepest drop was 9944.12% (2021).
  • Silo Pharma's Interest Expenses (Quarter) stood at $164.0 in 2021, then soared by 66.46% to $273.0 in 2023, then increased by 0.37% to $274.0 in 2024, then surged by 223.36% to $886.0 in 2025.
  • Its last three reported values are $886.0 in Q3 2025, $1648.0 for Q2 2025, and $2066.0 during Q1 2025.